Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

被引：0

作者：

Shohei Eto

Yoko Nukui

Miyuki Tsumura

Yu Nakagama

Kenichi Kashimada

Yoko Mizoguchi

Takanori Utsumi

Maki Taniguchi

Fumiaki Sakura

Kosuke Noma

Yusuke Yoshida

Shinichiro Ohshimo

Shintaro Nagashima

Keisuke Okamoto

Akifumi Endo

Kohsuke Imai

Hirokazu Kanegane

Hidenori Ohnishi

Shintaro Hirata

Eiji Sugiyama

Nobuaki Shime

Masanori Ito

Hiroki Ohge

Yasutoshi Kido

Paul Bastard

Jean-Laurent Casanova

Osamu Ohara

Junko Tanaka

Tomohiro Morio

Satoshi Okada

机构：

[1] Hiroshima University Graduate School of Biomedical and Health Science,Department of Pediatrics

[2] Tokyo Medical and Dental University Hospital,Department of Infection Control and Prevention

[3] Kyoto Prefectural University of Medicine,Department of Infection Control and Laboratory Medicine

[4] Osaka City University,Department of Parasitology, Graduate School of Medicine

[5] Tokyo Medical and Dental University,Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences

[6] Hiroshima University Hospital,Department of Clinical Immunology and Rheumatology

[7] Hiroshima University Graduate School of Biomedical and Health Science,Department of Emergency and Critical Care Medicine

[8] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Epidemiology Infectious Disease Control and Prevention

[9] Tokyo Medical and Dental University Hospital,Clinical Research Center

[10] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences

[11] Tokyo Medical and Dental University,Department of Child Health and Development

[12] Gifu University Graduate School of Medicine,Department of Pediatrics

[13] Emeritus Professor of Hiroshima University,Department of General Internal Medicine

[14] Hiroshima University Hospital,Department of Infectious Diseases

[15] Hiroshima University Hospital,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[16] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[17] Necker Hospital for Sick Children,Department of Applied Genomics

[18] University of Paris,undefined

[19] Imagine Institute,undefined

[20] The Rockefeller University,undefined

[21] Howard Hughes Medical Institute,undefined

[22] Kazusa DNA Research Institute,undefined

来源：

Journal of Clinical Immunology | 2022年 / 42卷

关键词：

COVID-19; Antibodies to type I IFNs; IFN-α2; IFN-ω; Neutralization assay; IFN-α2 concentration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1360 / 1370

页数：10

共 50 条

[1] Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
Eto, Shohei
Nukui, Yoko
Tsumura, Miyuki
Nakagama, Yu
Kashimada, Kenichi
Mizoguchi, Yoko
Utsumi, Takanori
Taniguchi, Maki
Sakura, Fumiaki
Noma, Kosuke
Yoshida, Yusuke
Ohshimo, Shinichiro
Nagashima, Shintaro
Okamoto, Keisuke
Endo, Akifumi
Imai, Kohsuke
Kanegane, Hirokazu
Ohnishi, Hidenori
Hirata, Shintaro
Sugiyama, Eiji
Shime, Nobuaki
Ito, Masanori
Ohge, Hiroki
Kido, Yasutoshi
Bastard, Paul
Casanova, Jean-Laurent
Ohara, Osamu
Tanaka, Junko
Morio, Tomohiro
Okada, Satoshi
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (07) : 1360 - 1370
[2] Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Aoki, Ami
Iwamura, Chiaki
Kiuchi, Masahiro
Tsuji, Kaori
Sasaki, Atsushi
Hishiya, Takahisa
Hirasawa, Rui
Kokubo, Kota
Kuriyama, Sachiko
Onodera, Atsushi
Shimada, Tadanaga
Nagaoka, Tetsutaro
Ishikawa, Satoru
Kojima, Akira
Mito, Haruki
Hase, Ryota
Kasahara, Yasunori
Kuriyama, Naohide
Nakamura, Sukeyuki
Urushibara, Takashi
Kaneda, Satoru
Sakao, Seiichiro
Nishida, Osamu
Takahashi, Kazuhisa
Kimura, Motoko Y.
Motohashi, Shinichiro
Igari, Hidetoshi
Ikehara, Yuzuru
Nakajima, Hiroshi
Suzuki, Takuji
Hanaoka, Hideki
Nakada, Taka-aki
Kikuchi, Toshiaki
Nakayama, Toshinori
Yokote, Koutaro
Hirahara, Kiyoshi
JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (04)
[3] Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai
Dongling Shi
Jie Chen
Meng Zhao
Yuanjia Tang
Chen Zhao
Yinpeng Jin
Di Tian
Yixin Liao
Xuebi Wang
Wei Wang
Xiaohong Fan
Zhigang Yi
Xiaohua Chen
Yun Ling
Journal of Clinical Immunology, 2024, 44
[4] Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai
Shi, Dongling
Chen, Jie
Zhao, Meng
Tang, Yuanjia
Zhao, Chen
Jin, Yinpeng
Tian, Di
Liao, Yixin
Wang, Xuebi
Wang, Wei
Fan, Xiaohong
Yi, Zhigang
Chen, Xiaohua
Ling, Yun
JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (03)
[5] Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
Jesús Troya
Paul Bastard
Laura Planas-Serra
Pablo Ryan
Montse Ruiz
María de Carranza
Juan Torres
Amalia Martínez
Laurent Abel
Jean-Laurent Casanova
Aurora Pujol
Journal of Clinical Immunology, 2021, 41 : 914 - 922
[6] Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
Troya, Jesus
Bastard, Paul
Planas-Serra, Laura
Ryan, Pablo
Ruiz, Montse
de Carranza, Maria
Torres, Juan
Martinez, Amalia
Abel, Laurent
Casanova, Jean-Laurent
Pujol, Aurora
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (05) : 914 - 922
[7] Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Strunz, Benedikt
Maucourant, Christopher
Mehta, Adi
Wan, Hui
Du, Likun
Sun, Dan
Chen, Puran
Nordlander, Anna
Gao, Yu
Cornillet, Martin
Bister, Jonna
Kvedaraite, Egle
Christ, Wanda
Klingstrom, Jonas
Geanon, Daniel
Parke, Asa
Ekwall-Larson, Anna
Rivino, Laura
MacAry, Paul A.
Aleman, Soo
Buggert, Marcus
Ljunggren, Hans-Gustaf
Pan-Hammarstrom, Qiang
Lund-Johansen, Fridtjof
Stralin, Kristoffer
Bjorkstrom, Niklas K.
JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (02) : e318 - e326
[8] Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients
Framil, Mario
Garcia-Serrano, Lydia
Morandeira, Francisco
Luchoro, Juan Francisco
Antoli, Arnau
Gomez-Vazquez, Jose Luis
Sierra-Fortuny, Angels
Solanich, Xavier
FRONTIERS IN IMMUNOLOGY, 2025, 16
[9] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Chauvineau-Grenier, Angelique
Bastard, Paul
Servajean, Antoine
Gervais, Adrian
Rosain, Jeremie
Jouanguy, Emmanuelle
Cobat, Aurelie
Casanova, Jean-Laurent
Rossi, Benjamin
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (03) : 459 - 470
[10] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Angélique Chauvineau-Grenier
Paul Bastard
Antoine Servajean
Adrian Gervais
Jérémie Rosain
Emmanuelle Jouanguy
Aurélie Cobat
Jean-Laurent Casanova
Benjamin Rossi
Journal of Clinical Immunology, 2022, 42 : 459 - 470

← 1 2 3 4 5 →